Canada sees HIV plant funds redirected to research

Millions of dollars once earmarked for a Canadian HIV vaccine-production facility now will be spent on research and preventing mother-to-child transmission of the virus, Health Minister Leona Aglukkaq has announced.  A partnership between the federal government and the Gates Foundation had set aside $88 million for a lab to produce pilot HIV vaccines, but the program was cancelled in February. That decision triggered controversy among scientists, as well as some harsh criticism from the companies that hoped to win the contract to build and operate it. Story

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.